glp-1 receptor agonist medicines Agonists: An Alternative for Rapid-Acting Insulin? Benefits and Risks of GLP-1

Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and isoglycemic intravenous glucose

Patients should be advised of these adverse effects prior to prescription

In a 2019 research summary, the agency noted: More than 2 million people now use exenatide worldwide. Part V: The Evolution of an Idea Byetta was a proof of concept, but it had limitations

Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted by intestinal L cells in response to dietary intake

How GLP-1 receptor agonists aid in weight loss

IQVIA data confirms combined Zepbound and Wegovy new patient starts increased 34% year-over-year in 2025